444 related articles for article (PubMed ID: 35715320)
21. Comparison of
Ling SW; de Jong AC; Schoots IG; Nasserinejad K; Busstra MB; van der Veldt AAM; Brabander T
Eur Urol Open Sci; 2021 Nov; 33():61-71. PubMed ID: 34632423
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis.
Wang S; Kozarek J; Russell R; Drescher M; Khan A; Kundra V; Barry KH; Naslund M; Siddiqui MM
Eur Urol Oncol; 2024 Apr; 7(2):189-203. PubMed ID: 37640584
[TBL] [Abstract][Full Text] [Related]
23. Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer.
Emmett L; Papa N; Hope TA; Fendler W; Calais J; Burger I; Eiber M; Barbato F; Moon D; Counter W; John N; Xue A; Franklin A; Thompson J; Rasiah K; Frydenberg M; Yaxley J; Buteau J; Agrawal S; Ho B; Nguyen A; Liu V; Lee J; Woo H; Hsiao E; Sutherland T; Perry E; Stricker P; Hofman MS; Kasivisvanathan V; Roberts M; Murphy D
J Urol; 2024 May; ():101097JU0000000000004010. PubMed ID: 38758680
[TBL] [Abstract][Full Text] [Related]
24. The Value of
Shi J; Li D; Chen M; Fu Y; Peng S; Zhang Q; Liang J; Lu Q; Lu J; Ai S; Wang F; Qiu X; Guo H
J Nucl Med; 2024 Apr; 65(4):555-559. PubMed ID: 38485278
[TBL] [Abstract][Full Text] [Related]
25. Detection of prostate cancer with
Bodar YJL; Jansen BHE; van der Voorn JP; Zwezerijnen GJC; Meijer D; Nieuwenhuijzen JA; Boellaard R; Hendrikse NH; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
World J Urol; 2021 Jul; 39(7):2439-2446. PubMed ID: 33079250
[TBL] [Abstract][Full Text] [Related]
26. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis.
Chow KM; So WZ; Lee HJ; Lee A; Yap DWT; Takwoingi Y; Tay KJ; Tuan J; Thang SP; Lam W; Yuen J; Lawrentschuk N; Hofman MS; Murphy DG; Chen K
Eur Urol; 2023 Jul; 84(1):36-48. PubMed ID: 37032189
[TBL] [Abstract][Full Text] [Related]
27. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.
Uleri A; Baboudjian M; Tedde A; Gallioli A; Long-Depaquit T; Palou J; Basile G; Gaya JM; Sanguedolce F; Lughezzani G; Rajwa P; Pradere B; Roupret M; Briganti A; Ploussard G; Breda A
Eur Urol Oncol; 2023 Dec; 6(6):621-628. PubMed ID: 37634971
[TBL] [Abstract][Full Text] [Related]
28. Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.
Doan P; Counter W; Papa N; Sheehan-Dare G; Ho B; Lee J; Liu V; Thompson JE; Agrawal S; Roberts MJ; Buteau J; Hofman MS; Moon D; Lawrentschuk N; Murphy D; Stricker PD; Emmett L
BJU Int; 2023 May; 131(5):588-595. PubMed ID: 36371669
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity, Specificity, and Predictors of Positive
Perera M; Papa N; Christidis D; Wetherell D; Hofman MS; Murphy DG; Bolton D; Lawrentschuk N
Eur Urol; 2016 Dec; 70(6):926-937. PubMed ID: 27363387
[TBL] [Abstract][Full Text] [Related]
31. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
[TBL] [Abstract][Full Text] [Related]
32. Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
Geboers B; Meijer D; Counter W; Blazevski A; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; O'Neill G; Yuen C; Vis AN; van Leeuwen PJ; Ho B; Liu V; Lee J; Donswijk ML; Oprea-Lager D; Scheltema MJ; Emmett L; Stricker PD
BJU Int; 2024 Apr; 133 Suppl 4():14-22. PubMed ID: 37858931
[TBL] [Abstract][Full Text] [Related]
33.
Yang J; Li J; Xiao L; Zhou M; Fang Z; Cai Y; Tang Y; Hu S
Cancer Imaging; 2023 Sep; 23(1):81. PubMed ID: 37667341
[TBL] [Abstract][Full Text] [Related]
34.
Liu C; Liu T; Zhang Z; Zhang N; Du P; Yang Y; Liu Y; Yu W; Li N; Gorin MA; Rowe SP; Zhu H; Yan K; Yang Z
J Nucl Med; 2020 Sep; 61(9):1314-1319. PubMed ID: 32034111
[TBL] [Abstract][Full Text] [Related]
35. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy.
Kelly BD; Ptasznik G; Roberts MJ; Doan P; Stricker P; Thompson J; Buteau J; Chen K; Alghazo O; O'Brien JS; Hofman MS; Frydenberg M; Lawrentschuk N; Lundon D; Murphy DG; Emmett L; Moon D
Eur Urol Open Sci; 2023 Jul; 53():90-97. PubMed ID: 37441340
[TBL] [Abstract][Full Text] [Related]
36. Current state of prostate-specific membrane antigen PET/CT imaging-targeted biopsy techniques for detection of clinically significant prostate cancer.
Ma L; Zhang WC; Hao YX
J Med Imaging Radiat Oncol; 2022 Sep; 66(6):776-780. PubMed ID: 34914195
[TBL] [Abstract][Full Text] [Related]
37.
Gondoputro W; Doan P; Katelaris A; Scheltema MJ; Geboers B; Agrawal S; Liu Z; Yaxley J; Savdie R; Rasiah K; Frydenberg M; Roberts MJ; Malouf D; Wong D; Shnier R; Delprado W; Emmett L; Stricker PD; Thompson J
Transl Androl Urol; 2023 Oct; 12(10):1598-1606. PubMed ID: 37969779
[TBL] [Abstract][Full Text] [Related]
38. Detection Rate of
Pepe P; Pepe L; Cosentino S; Ippolito M; Pennisi M; Fraggetta F
Anticancer Res; 2022 Jun; 42(6):3011-3015. PubMed ID: 35641295
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study).
Woo HH; Khanani H; Thompson NJ; Sorensen BJ; Baskaranathan S; Bergersen P; Chalasani V; Dean T; Dias M; Symons J; Wines M; Jain A; Nassour AJ; Tarlinton LC
Eur Urol Open Sci; 2023 Jan; 47():119-125. PubMed ID: 36601041
[TBL] [Abstract][Full Text] [Related]
40. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
